Abstract
In the crystal structure of the reduced form of the wild-type human peroxiredoxin 5, the presence of a benzoate ion in direct interaction with the peroxidatic cysteine (Cys 47) appeared as a rather intriguing feature since it is known that the benzoate ion can play the role of a specific hydroxyl radical scavenger. The crystal structure of the C47S mutant of the same enzyme has been crystallized in the tetragonal system, space group P4 122, with a = 65.65 Å, c = 122.04 Å. It confirms the presence of this benzoate ion in spite of the mutation into a serine of the Cys 47 residue to which the benzoate ion was directly linked in the wild-type structure. The benzoate ion seems to be stabilized by hydrophobic contacts on both sides of the aromatic ring. In this matter, the α5 helix, which is specific to peroxiredoxin 5 among mammalian peroxiredoxins, plays an important role. These hydrophobic contacts also allow to suggest why the benzoate ion disappears when the molecule is oxidized.
Similar content being viewed by others
References
Rhee, S.G.; Kang, S.W.; Chang, T.S.; Jeong, W.; Kim, K. IUBMB Life 2001, 52, 35.
Wood, Z.A.; Poole, L.B.; Hantgan, R.R.; Karplus, P.A. Biochemistry 2002, 41, 5493.
Hofmann, B.; Hecht, H.-J.; Flohé, L. Biol. Chem. 2002, 383, 347.
Hirotsu, S.; Abe, Y.; Okada, K.; Nagahara, N.; Hori, H.; Nishino, T.S.; Hakoshima, T. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 12333.
Schröder, E.; Littlechild, J.A.; Lebedev, A.A.; Errington, N.; Vagin, A.A.; Isupov, M.N. Structure 2000, 8, 605.
Alphey, M.S.; Bond, C.S.; Tetaud, E.; Fairlamb, A.H.; Hunter, W.N. J. Mol. Biol. 2000, 300, 903.
Choi, H.J.; Kang, S.W.; Yang, C.H.; Rhee, S.G.; Ryu, S.E. Nat. Struct. Biol. 1998, 5, 400.
Knoops, B.; Clippe, A.; Bogard, C.; Arsalane, K.; Wattiez, R.; Hermans, C.; Duconseille, E.; Falmagne, P.; Bernard, A. Biol. Chem. 1999, 274, 30451.
Seo, M.S.; Kang, S.W.; Kim, K.; Baines, I.C.; Lee, T.H.; Rhee, S.G. J. Biol. Chem. 2000, 275,20346.
Declercq, J.P.; Evrard, C.; Clippe, A.; Vander Stricht, D.; Bernard, A.; Knoops, B.J. Mol. Biol. 2001, 311, 751.
Declercq, J.P.; Evrard, C. Acta Crystallogr. 2001, D57, 1829.
Evrard, C.; Capron, A.; Marchand, C.; Clippe, A.; Wattiez, R.; Soumillion, P.; Knoops, B.; Declercq, J.P. J. Mol. Biol. 2004, 337, 1079.
Sagone, A.L.; Decker, M.A.; Wells, R.M.; Democko, C. Biochim. Biophys. Acta 1980, 628, 90.
Plaisant, F.; Clippe, A.; Vander Stricht, D.; Knoops, B.; Gressens, P. Free Rad. Biol. Med. 2003, 34, 862.
Otwinowski, Z.; Minor, W. Methods Enzymol. 1997, 276, 307.
Brünger, A.T. Nature 1992, 355, 472.
Murshudov, G.N.; Vagin, A.A.; Dodson, E.J. Acta Cryst. 1997, D53, 240.
Collaborative Computational Project, Number 4. Acta Cryst. 1994, D50, 760.
Jones, T.A.; Zou, J.-Y.; Cowan, S.W.; Kjeldgaard, M. Acta Cryst. 1991, A47, 110.
Perrakis, A.; Morris, R.M.; Lamzin, V.S. Nat. Struct. Biol. 1999, 6, 458.
Kraulis, P.J. J. Appl. Cryst. 1991, 24, 946.
Merritt, E.A.; Bacon, D.J. Methods Enzymol. 1997, 277, 505.
Martin, J.L. Structure 1995, 3, 245.
Hofmann, B.; Tölzer, S.; Pelletier, I.; Altenbuchner, J.; van Pée, K.H.; Hecht, H.J. J. Mol. Biol. 1998, 279, 889.
Halliwell, B.; Grootveld, M.; Gutteridge, J.M.C. Meth. Biochem. Anal. 1988, 33, 59.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Evrard, C., Smeets, A., Knoops, B. et al. Crystal structure of the C47S mutant of human peroxiredoxin 5. Journal of Chemical Crystallography 34, 553–558 (2004). https://doi.org/10.1023/B:JOCC.0000042025.08082.6c
Issue Date:
DOI: https://doi.org/10.1023/B:JOCC.0000042025.08082.6c